Global cryptocurrency market capitalization is trading 2.5% higher to $2.99 trillion. One trader predicts the weekend to be choppy, with a push higher predicted for next week. Don't face extreme market conditions unprepared.

FDA approved penpulimab-kcqx for first- and later-line treatment of metastatic non-keratinizing NPC in adults. Phase 3 HARMONi trials showed ivonescimab improved PFS over Keytruda and tislelizumab in NSCLC patients. Today's manic market swings are creating the perfect setup for Matt's next ...

Tariffs may cost PG up to $1.5 billion annually. Analyst lowers FY25, FY26 margin and EPS forecasts. Feel unsure about the market's next move? Copy trade alerts from Matt Maley-a Wall Street veteran who consistently finds profits in volatile markets. Claim your 7-day free trial now.

Nasdaq has urged the US Securities and Exchange Commission ( SEC ) to hold digital assets to the same regulatory standards as securities if they constitute "stocks by any other name," according to an April 25 comment letter.

New York City, April 25, 2025 ( GLOBE NEWSWIRE ) -- What collagen is and how it naturally declines with age, contributing to common aging concerns Why hydrolyzed grass-fed collagen peptides are gaining popularity for skin, joint, and gut support

NEW YORK, April 25, 2025 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Profound Medical Corp. ( "Profound" or the "Company" ) PROF. Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

Medical device company Semler Scientific-which trades on the Nasdaq-now holds 3,303 Bitcoin after its latest buy.

NEW YORK, April 25, 2025 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Methanex Corporation ( "Methanex" or the "Company" ) MEOH. Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

Last week, I suggested that you buy bonds instead of stocks. It's the smart play.

Tariffs, trade policy, and the risk of recession have all contributed to market turmoil lately. That's led to a massive increase in volatility in one of the market's biggest stocks. Shares in tech giant Nvidia ( NASDAQ: NVDA ) have been rebounding sharply in recent days after a more than 20% drop ...